Who We Are

About Strassenburg

Strassenburg seeks to serve Indian patients with affordable drugs of the highest quality. Every action and decision taken within the organization is guided by this philosophy. Established in 1985 in Calcutta, we have been able to grow significantly over the decades, while never compromising on our ethical or scientific standards. Our credo – “From Research to Relief” has encouraged us to seek niches of expertise and inventiveness, ultimately resulting in three litmus tests through which all our undertakings must pass: quality, safety, and affordability.

Principles of Our Work

  • Patient-Centric Focus: Every decision we make revolves around the well-being and health of our patients, ensuring that their needs are at the forefront of our innovations.
  • Commitment to Quality: We adhere to the highest standards of quality in every aspect of our operations, from research and development to manufacturing and distribution.
  • Innovation-Driven: We continually seek out and integrate cutting-edge technologies and research to develop advanced pharmaceutical solutions that address unmet medical needs.
  • Continuous Improvement: We are committed to lifelong learning and continuous improvement, striving to enhance our processes, products, and services.

Awards

Strassenburg’s manufacturing facility is WHO-GMP certified, and also houses a DSIR-approved R&D facility. We received the Economic Times Award for ‘Best Financial Performance’ in West Bengal, 2015.

Mission: Delivering world-class medicines by adhering to the highest standards of pharmaceutical manufacturing.

Vision: to become a global leader in pragmatic and low-cost healthcare innovation.

Leadership

“Purpose, Passion and Process Unite us here at Strassenburg”

Deepnath Roy Chowdhury

Founder and MD
Deepanshu Roy Chowdhury

Deepnath Roy Chowdhury founded Strassenburg in 1985, in the city of Calcutta. Under his guidance, we have been able to establish ourselves as a pharmaceutical house that truly puts ethics first. From beginning as a niche manufacturer of oral solid and liquid formulations in eastern India to being a national leader in the GI and surgery segments – ours has been a story of perseverance and sustainable growth.

By always putting process before results, ‘the Strassenburg way’ serves as a North Star to all members of the organization, our partners, and finally our customers. Strassenburg’s first customers are it’s employees – our ‘people first’ approach has been one of the key differentiating factors in a highly-competitive environment.

This mentality is a key cultural contribution of our founder. Our commitment to research, innovation, and affordability can also be traced back to Mr. Roy Chowdhury’s vision and conviction in these ideals.

Aside from Strassenburg, Deepnath Roy Chowdhury has also held leadership positions in the Indian Drug Manufacturers Association (IDMA) – including but not limited to acting as the body’s National President between 2017-2019. He continues to serve the Indian pharmaceutical industry as a veteran today, prioritizing the growth of the entire sector collectively.

Our History

1980s

Strassenburg Pharmaceuticals was incorporated in 1985 in Kolkata, India with the clear vision of providing affordable, quality medicines to Indian citizens.

1990s

Strassenburg was the first to introduce Sucralfate to the Indian Medical Fraternity for the treatment of Peptic Ulcer Diseases with the introduction of its brand Sucral.

For faster relief from painful gastritis, Sucral was fortified with the local anaesthetic Oxetacaine and Sucral O was introduced.

Today treatment of Gastric Erosion & ulcers remains incomplete without Sucral & Sucral-O.

Sucral and Sucral-O have saved millions of critically ill patients admitted to CCU.

2000s

The innovative idea of topical sucralfate therapy, in the form of Sucral cream, for the treatment of burns was first presented to the medical community worldwide by Strassenburg.

2010s

Sucral Cream

Sucral ANO was the first specific therapy for Anal Fissure to be introduced in India. Sucral ANO heralded a new segment – topical non-steroidal-anorectal in anorectal therapy.

Sucral MU Ointment is a Value-added Mupirocin proven by clinical trials.

2020s

In collaboration with Palani LLC, USA, ErasaVir nasal and mouth sprays were introduced in India to combat the menace of the COVID-19 pandemic.

Post COVID, ErasaVir is being promoted for respiratory well-being.

Social Responsibility

Social Responsibility

At Strassenburg, we see ourselves as part of a larger whole. This community mindset has blessed us with the goodwill of countless employees, doctors, and patients alike. Our commitment to society is not separate from our vision of growth. To this end we are constantly trying to do our bit to make our community a better place.